Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06438549 · ClinicalTrials.gov registry record · NA
Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation
A NA study of Tobacco Use and Tobacco Use Cessation, sponsored by Loma Linda University.
- Recruiting
- Registry status
- NA
- Development phase
- 105
- Enrollment target
- 2
- Study locations
NCT06438549: Recruiting NA study of Tobacco Use and Tobacco Use Cessation, sponsored by Loma Linda University.
NCT06438549 is a NA study of Tobacco Use and Tobacco Use Cessation that is actively recruiting participants, run by Loma Linda University. The registered enrollment target is 105 participants, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06438549, a NA study of Tobacco Use and Tobacco Use Cessation, is actively recruiting participants, sponsored by Loma Linda University.
- RECRUITING
- Registry status
- NA
- Development phase
- 105 participants
- Enrollment target
- 2
- Study locations
Study Summary
This develops a novel behavioral tobacco cessation program for pregnant smokers in San Bernardino County.
Primary Outcome
The 7 Day Point Prevalence Abstinence (PPA) questionnaire will be administered to subjects to assess the following: Tobacco use within past seven days
Conditions Studied
Interventions
- OTHER Control Arm
- BEHAVIORAL HCP-CHW Integration into Prenatal Care for Smoking Cessation
Study Locations (2)
California
- Loma Linda University Medical Center - Loma Linda
- Riverside University Health Systems - Moreno Valley
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2024-05-24 |
| Est. Completion | 2026-08 |
| Phase | NA |
What NCT06438549 shows while recruiting
NCT06438549 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, below the 378-participant average among 76 other Tobacco Use trials with a reported enrollment target (72% lower).
The record links to 3 conditions, with Tobacco Use appearing as the primary indexed condition, and to 2 interventions - of which Control Arm is the first listed.
NCT06438549 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06438549 about?
NCT06438549 is a clinical study titled "Integrating CHWs Into Prenatal Care for Maternal Smoking Cessation". This develops a novel behavioral tobacco cessation program for pregnant smokers in San Bernardino County.
What is the current status of trial NCT06438549?
This trial is currently recruiting. It is a NA study. The enrollment target is 105 participants. The study started on 2024-05-24. Estimated completion is 2026-08.
What conditions does trial NCT06438549 study?
This clinical trial studies the following conditions: Tobacco Use, Tobacco Use Cessation, Tobacco Use in Childbirth.
What interventions are being tested in trial NCT06438549?
The interventions under investigation include: Control Arm (OTHER), HCP-CHW Integration into Prenatal Care for Smoking Cessation (BEHAVIORAL).
Who is sponsoring clinical trial NCT06438549?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06438549 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tobacco Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06438549's enrollment target sits among peer trials
105 37th of 76 higher than 40 of 76 other Tobacco Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Tobacco Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Nonendoscopic Screening for Barrett's Esophagus in Veterans Without Chronic Reflux
RECRUITING · NA
-
Opioids, Low Nicotine Cigarettes, and Chronic Pain
RECRUITING · NA
-
Reach Through Equitable Implementation in Utah
RECRUITING · NA
-
RTMS Targets Neural Circuits for Smoking Cessation
RECRUITING · NA
-
Cigar Legislation and Regulation in Tobacco for the Young (Project CLARITY)
RECRUITING · NA
-
Catalyzing Cigarette Smoking Cessation Through Harm Reduction Sampling Among People Unmotivated to Quit
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI